Clinical trial
Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
NCT04779593 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
- Lead sponsor
- Rennes University Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 2, 2021
- Completion date
- January 31, 2027
- Enrollment
- 239 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
haemochromatosis